U01.05.016 Micturition control

Micturition, or the process of urination, is controlled by a complex system involving the brain, spinal cord, and various nerves. The pons house the micturition center, which regulates the involuntary bladder function by coordinating the sympathetic and parasympathetic nervous systems. Understanding the mechanisms of bladder control and the drugs that influence it is important for the USMLE Step 1.

Key Components of Micturition Control

The coordination between the sympathetic, parasympathetic, and somatic nervous systems is essential for proper bladder function. Below is a breakdown of these systems and the associated receptors.

Nervous System Involvement

Nerve Type	Function	Receptor/Effect
Sympathetic (Hypogastric nerve)	Promotes urinary retention	α1-receptor: Contraction of internal urethral sphincter
Parasympathetic (Pelvic nerve)	Promotes bladder voiding	M3-receptor: Contraction of detrusor muscle
Somatic (Pudendal nerve)	Controls voluntary sphincter contraction	Nicotinic receptor: Contraction of external urethral sphincter

Mechanism of Drug Action on Bladder Function

Certain drugs affect the receptors involved in micturition, influencing bladder function and treating conditions like urinary retention and incontinence.

Drug Class	Drug Example	Mechanism of Action	Clinical Use
Muscarinic Antagonists	Oxybutynin	Block M3 receptors: Relaxes detrusor smooth muscle	Treats urgency incontinence
Muscarinic Agonists	Bethanechol	Stimulates M3 receptors: Contraction of detrusor muscle	Treats urinary retention
Sympathomimetics	Mirabegron	Stimulates β3 receptors: Relaxes detrusor smooth muscle	Treats urgency incontinence
α1-Blockers	Tamsulosin	Block α1-receptors: Relaxes smooth muscle (bladder neck, prostate)	Treats BPH (Benign Prostatic Hyperplasia)

Receptors Involved in Bladder Control

M3 Receptor: Present on detrusor muscle; when activated, causes contraction, leading to urination.
β3 Receptor: Present on detrusor muscle; when activated, causes relaxation, increasing bladder capacity.
α1 Receptor: Located on internal urethral sphincter and smooth muscle; when activated, it causes contraction, leading to urinary retention.
Nicotinic Receptor: Located on the external urethral sphincter; when activated, it causes contraction, allowing voluntary control over micturition.

Points to Remember

Sympathetic System: Involved in urinary retention via activation of α1-receptors in the bladder neck.
Parasympathetic System: Promotes urine voiding through M3-receptor activation in the detrusor muscle.
Somatic Control: Voluntary control of the external urethral sphincter via the pudendal nerve and Nicotinic receptors.
Drug Mechanisms:
- Muscarinic antagonists (e.g., Oxybutynin) are used to treat urgency incontinence by relaxing the detrusor muscle.
- Muscarinic agonists (e.g., Bethanechol) are used to treat urinary retention by stimulating detrusor contraction.
- Sympathomimetics (e.g., Mirabegron) are used to treat urgency incontinence by relaxing the detrusor muscle.
- α1-blockers (e.g., Tamsulosin) are used to treat BPH by relaxing the smooth muscle in the bladder neck, and prostate.

USMLE Step 1 Review Series

Curriculum